Relationship between thrombin activated fibrinolysis inhibitor in plasma and changes of coagulant and fibrinolytic function in type 2 diabetes
- VernacularTitle:血浆纤溶抑制物与2型糖尿病患者凝血及纤溶功能变化的关系
- Author:
Lanjun ZHONG
;
Xiaona LI
;
Jinfang DING
- Publication Type:Journal Article
- Keywords:
Plasminogen inactivators;
Diabetes mellitus,type 2;
Blood coagulation;
Fibrinolysis
- From:
International Journal of Laboratory Medicine
2006;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the relationship of thrombin activated fibrinolysis inhibitor (TAFI) in plasma with changes of coagulant and fibrinolytic function in type 2 diabetes.Methods The plasma level of TAFI was measured by ELISA, fibrinogen was analyzed with Clauss assay and plasminogen was detected by chromogenic assay.Results The plasma levels of TAFI, Fib and the activity of PLG were significantly increased in type 2 diabetes with (P
